Steven Chartier

Suggest Changes
  • Citations Per Year
Learn More
Interleukin 2 (IL-2) administered at low doses for prolonged periods can markedly expand the number of CD56(+) natural killer (NK) cells in patients with metastatic cancer. The cytotoxic capacity of(More)